Pear Therapeutics, Inc.·4

Feb 17, 4:14 PM ET

O'Brien Ronan 4

4 · Pear Therapeutics, Inc. · Filed Feb 17, 2023

Insider Transaction Report

Form 4
Period: 2023-02-15
O'Brien Ronan
General Counsel & Secretary
Transactions
  • Award

    Restricted Stock Units

    2023-02-15+1,295,2381,295,238 total
    Class A Common Stock (1,295,238 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of PEAR Class A Common Stock.
  • [F2]The restricted stock units shall vest and settle as to 33% on February 15, 2024; 33% on February 15, 2025; and 34% on February 15, 2026.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES